Analysis & Opinions
October 12, 2012
On a bad day for the market, the Nasdaq has declined 0.2%, the S&P 500 has slipped 0.4% and the Dow has fallen 0.2%. ...
July 12, 2012
XenoPort, Inc. (XNPT) and Astellas Pharma Inc. recently announced the launch of Regnite extended-release tablets in ...
June 12, 2012
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (XNPT) recently announced that their drug, Horizant, has been approved ...
April 11, 2011
Xenoport's pipeline is thin, but Horizant approval buys valuable time.
March 03, 2011
Salix has taken another blow from the FDA, but seems too cheap given its prospects.
February 23, 2010
The biotech sector lagged the market in 2009, but it is off to a great start in 2010.